RAC 5.59% $1.70 race oncology ltd

Ann: Zantrene Improves Immune Therapy Treatment of Melanoma, page-67

  1. 709 Posts.
    lightbulb Created with Sketch. 277
    HC, that is true however it allowed a much longer trial (35 days) and this allowed the authors to look at animal survival data as well as tumor size.
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.